## Diagnosis of VAP: Invasive Sampling **Key Point:** Quantitative bronchoalveolar lavage (BAL) with culture is the gold standard for diagnosing VAP because it provides organism identification with quantitative thresholds that distinguish true infection from colonization, guiding targeted therapy. ### Why Quantitative BAL for VAP? 1. **Quantitative threshold** — BAL culture ≥10^4 CFU/mL distinguishes infection from colonization; ETA does not. 2. **Highest specificity** — >95% specificity for true VAP; reduces unnecessary broad-spectrum antibiotics. 3. **Organism identification** — Identifies causative pathogen and allows susceptibility-guided therapy. 4. **Reduced antibiotic overuse** — Quantitative results prevent empirical escalation in colonized patients. ### Comparison: ETA vs. Quantitative BAL in VAP | Feature | ETA (Non-quantitative) | Quantitative BAL | | --- | --- | --- | | **Sensitivity** | 60–80% | 70–90% | | **Specificity** | 40–60% (colonization not excluded) | >95% (threshold-based) | | **Threshold** | None (qualitative) | ≥10^4 CFU/mL = VAP | | **Invasiveness** | Minimal (suctioning) | Moderate (bronchoscopy) | | **Timing** | Immediate | 24–48 hours | | **Clinical use** | Screening; high false-positive rate | Diagnostic confirmation | **High-Yield:** IDSA/ATS VAP guidelines recommend **quantitative BAL** (≥10^4 CFU/mL) or **quantitative ETA** (≥10^5 CFU/mL) for diagnosis. Non-quantitative ETA culture has poor specificity and leads to overtreatment. Quantitative thresholds are essential to distinguish true infection from airway colonization. **Mnemonic: "BAL 4, ETA 5"** — BAL ≥10^**4** CFU/mL or ETA ≥10^**5** CFU/mL = VAP diagnosis. ### VAP Diagnostic Algorithm ```mermaid flowchart TD A[Ventilated patient + fever + new infiltrate + purulent secretions]:::outcome --> B{Quantitative culture available?}:::decision B -->|Yes: BAL or quantitative ETA| C{CFU/mL threshold met?}:::decision C -->|BAL ≥10^4 or ETA ≥10^5| D[VAP confirmed]:::outcome C -->|Below threshold| E[Colonization; consider other diagnosis]:::outcome B -->|No: only non-quantitative ETA| F[High false-positive risk; consider repeat with quantitative method]:::action D --> G[Organism-directed therapy]:::action E --> H[De-escalate or stop antibiotics]:::action ``` **Clinical Pearl:** Early VAP (days 1–4) is often caused by community flora (*S. pneumoniae*, *H. influenzae*); late VAP (≥5 days) by multidrug-resistant gram-negatives (*P. aeruginosa*, *A. baumannii*, MRSA). Quantitative BAL guides targeted empirical coverage. [cite:Harrison 21e Ch 297]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.